Opioid Crisis: Florida Jury Deliberates in Trial Against Major Pharmacies
A Reckoning in the Sunshine State: Will Major Pharmacies Be Held Accountable for the Opioid Crisis?
The opioid crisis continues to cast a long shadow over communities across the United States, and Florida is no exception. In 2022, the state recorded over 7,600 overdose deaths, highlighting the urgent need for effective strategies to combat this epidemic. While these numbers have decreased since 2021, Florida’s population-adjusted rate remains above the national average, underscoring the ongoing public health challenges. Now, a Florida jury is deliberating in a closely watched trial that could have significant implications for the role of major pharmacies in the crisis. But how did we get here, and what’s at stake?
The Opioid Epidemic in Florida: A State Grappling with Devastation
Florida has been profoundly affected by the opioid crisis. In the first six months of 2016 alone, the state recorded 2,664 opioid-related deaths. The crisis peaked between 2020 and 2022, with the highest overdose death rates in Florida’s history. While there has been a modest improvement, with the synthetic opioid death rate declining from 24.3 to 21.5 per 100,000 residents between 2022 and 2023, opioids were still implicated in over 6,000 fatalities in 2022.
The rise of fentanyl has been a game changer. Over 50 times more potent than heroin, fentanyl often kills quickly. According to the U.S. Drug Enforcement Administration (DEA), drug dealers now add fentanyl and fentanyl analogs to almost every type of illicit drug.
The Legal Landscape: Holding Pharmacies Accountable
In 2019, multiple Florida hospitals sued major pharmacy chains, including Walgreens, Walmart, and CVS, accusing them of racketeering by filling prescriptions for painkillers known as opioids. These lawsuits allege that the pharmacies’ actions led to widespread addiction and overdose deaths across the U.S.
These lawsuits are built on the argument that pharmacies have a “corresponding responsibility” to ensure that controlled substances are dispensed responsibly. This principle, established by the DEA in 1971, states that a pharmacist shares responsibility with the prescribing practitioner for the proper dispensing of controlled substances.
The Pharmacist as Gatekeeper
A key argument in the Florida trial is that pharmacists serve as “gatekeepers” in dispensing opioid medications. As Dr. Andrew Kolodny, medical director for the Opioid Policy Research Collaborative at Brandeis University, testified, “A pharmaceutical company can’t make money on sales of its product if pharmacists don’t dispense the product.”
The plaintiffs in the Florida case argue that pharmacies failed to adequately monitor and prevent the dispensing of suspicious prescriptions. They claim that the pharmacies’ policies incentivized fulfillment speed, preventing pharmacists from properly resolving “red flag” concerns about the validity of opioid prescriptions.
Echoes of Past Verdicts: Precedent and Public Nuisance
The Florida trial is not the first time major pharmacies have faced legal action over their role in the opioid crisis. In 2021, a federal jury in Cleveland found CVS, Walgreens, and Walmart liable for contributing to the opioid epidemic in two Ohio counties. This verdict marked the first time the retail segment of the drug industry was held accountable in the decades-long opioid epidemic.
The Ohio counties argued that the pharmacies created a public nuisance by enabling the opioid crisis, costing them approximately $1 billion each in expenses related to law enforcement, social services, and courts. While this legal argument has been rejected in some cases against opioid manufacturers, the Ohio verdict suggests that it can be successful against pharmacies.
The Stakes in Florida: Billions of Dollars and a Path Forward
The state of Florida has spent an estimated $14 billion over the last 20 years on opioid-related costs, ranging from criminal justice to drug rehabilitation and treatment for opioid-addicted infants. Florida has already collected more than $3 billion from other pharmaceutical companies over the course of its “historic” opioid litigation. The state could seek similar massive damages from Walgreens in the jury trial.
The Other Side of the Counter: Arguments from the Defense
Pharmacy chains have countered these claims by arguing that doctors and other healthcare practitioners who write prescriptions bear the ultimate responsibility for improper distribution of opioids. They argue that pharmacists are not trained as physicians and should not be held liable for filling legal prescriptions written by DEA-licensed doctors.
Some experts also point to the role of “pill mills,” internet pharmacies, and independent pharmacies in fueling the opioid crisis. They argue that these entities often dispensed medications in greater volumes than the chain pharmacies being sued.
Beyond the Courtroom: Addressing the Opioid Crisis in Florida
Regardless of the outcome of the Florida trial, addressing the opioid crisis requires a multifaceted approach. Florida has implemented several strategies to combat the epidemic, including:
- Prevention: A wide range of activities aimed at reducing risks or threats to health.
- Treatment: Expanding access to evidence-based treatment for opioid use disorder.
- Recovery & Peer Supports: Supporting individuals in their recovery journey through peer support programs and other resources.
- Technology/Data Exchange: Utilizing technology and data to improve surveillance and response efforts.
- Coordinated Opioid Recovery (CORE) Network: A comprehensive network of addiction and opioid treatment.
The Verdict Awaited: A Turning Point for Accountability?
As the jury deliberates in the Florida trial, the stakes are high. A verdict against the major pharmacy chains could pave the way for further legal action and potentially billions of dollars in damages. More importantly, it could send a strong message that pharmacies must be held accountable for their role in preventing the diversion and abuse of prescription painkillers.
If you or a loved one has been affected by the opioid crisis, it’s important to understand your legal rights. Contact our firm today for a free consultation to discuss your options.